AI assistant
Sending…
Altimmune, Inc. — Director's Dealing 2025
Oct 3, 2025
33207_dirs_2025-10-03_14860df6-97e8-49f2-8a9a-6b9ee8b0fb8d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Altimmune, Inc. (ALT)
CIK: 0001326190
Period of Report: 2025-10-01
Reporting Person: Arbet-Engels Christophe (Chief Medical Officer)
More from Altimmune, Inc.
Share Issue/Capital Change
2026
May 13
Regulatory Filings
2026
May 13
Capital/Financing Update
2026
Apr 22
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 16
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 17
Proxy Solicitation & Information Statement
2026
Mar 17
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Regulatory Filings
2026
Feb 6